- Home
- KRON vs MDCX Comparison
KRON vs MDCX Comparison
Compare KRON & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRON
- MDCX
- Stock Information
- Founded
- KRON 2017
- MDCX 2008
- Country
- KRON United States
- MDCX Canada
- Employees
- KRON N/A
- MDCX N/A
- Industry
- KRON Medicinal Chemicals and Botanical Products
- MDCX
- Sector
- KRON Health Care
- MDCX
- Exchange
- KRON Nasdaq
- MDCX Nasdaq
- Market Cap
- KRON 41.5M
- MDCX 44.0M
- IPO Year
- KRON 2020
- MDCX N/A
- Fundamental
- Price
- KRON $0.87
- MDCX $2.52
- Analyst Decision
- KRON Buy
- MDCX Strong Buy
- Analyst Count
- KRON 3
- MDCX 2
- Target Price
- KRON $1.63
- MDCX $23.50
- AVG Volume (30 Days)
- KRON 1.4M
- MDCX 426.1K
- Earning Date
- KRON 08-07-2025
- MDCX 05-12-2025
- Dividend Yield
- KRON N/A
- MDCX N/A
- EPS Growth
- KRON N/A
- MDCX N/A
- EPS
- KRON N/A
- MDCX N/A
- Revenue
- KRON $9,192,000.00
- MDCX N/A
- Revenue This Year
- KRON N/A
- MDCX N/A
- Revenue Next Year
- KRON N/A
- MDCX N/A
- P/E Ratio
- KRON N/A
- MDCX N/A
- Revenue Growth
- KRON 21.16
- MDCX N/A
- 52 Week Low
- KRON $0.65
- MDCX $1.80
- 52 Week High
- KRON $1.60
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- KRON 64.27
- MDCX N/A
- Support Level
- KRON $0.87
- MDCX N/A
- Resistance Level
- KRON $0.90
- MDCX N/A
- Average True Range (ATR)
- KRON 0.02
- MDCX 0.00
- MACD
- KRON 0.01
- MDCX 0.00
- Stochastic Oscillator
- KRON 87.65
- MDCX 0.00
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.